Dr. Larry Markham’s interests and investigations have been focused in congenital heart conditions, particularly adult congenital heart disease, transition of care, and inherited conditions with a cardiovascular phenotype. In 2018, Dr. Markham came to Indiana University from Vanderbilt University where he was the Director of the Adult Congenital Heart Program. One particular area of focus has been exploring predictors of Duchenne Muscular Dystrophy cardiomyopathy to understand the heart muscle disease progression and determine therapeutic options. Dr. Markham served as a member of the National Institutes of Health/NINDS Cardiac Working group, co-chair of the 2014 Parent Project Muscular Dystrophy and the National Heart, Lung, and Blood Institute-sponsored Working Group on Contemporary Cardiac Issues in Duchenne Muscular Dystrophy, and co-author of the 2017 American Heart Association Scientific Statement entitled “Management of Cardiac Involvement Associated With Neuromuscular Diseases.” Another area of focus has been inherited conditions with aortic disease such as Marfan syndrome and Loeys Dietz syndrome. Dr. Markham served as the site PI for the National Institutes of Health/NHLBI Pediatric Heart Network Marfan Trial and remains an active participant in multiple writing committees. Dr. Markham has mentored junior faculty members to publication and NIH funding. In summary, Dr. Markham has demonstrated a record of expertise in the field of congenital and inherited cardiac care, experience with clinical research including multi-institutional clinical trials, and publication of results.